drugset / Trial / NCT05866471

The ENHANCE Study: taVNS and Psilocybin

NCT05866471

RandomizedFactorialTriple-blindBasic science

Summary

This study will examine whether combining a single dose of psilocybin with non-invasive transcutaneous auricular vagus nerve stimulation (taVNS), a potential inducer of neuroplasticity and enhanced memory formation, will enhance the long-term beneficial behavioral effects of psilocybin when compared to sham taVNS or no VNS by allowing memory for insights gained during the psychedelic experience to remain vivid after they will have faded in subjects who receive psilocybin followed by sham taVNS or no VNS.

Timeline

Start
2025-01-27
Primary completion
2027-11
Completion
2028-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified 25 mg